ATS Automation Tooling Systems Inc. announced it has received a $20 million order booking from a medical device manufacturer to design, build, and deliver several automated safety syringe manufacturing systems that will feature the Company’s high-performance Symphoni technology. The program will be completed over the next 10 months and will enable the production of safety syringes to meet potential demand related to COVID-19 vaccine production.
ATS Automation’s modular Symphoni technology combines the speed of continuous motion with the precision and flexibility of robotic assembly.
in In 2017, Transformix launched the newest iteration of their platfrom, an initiative designed to repackage the technology into a set of configurable, plug-and-play modules. As part of this initiative, the company carried out a top-to-bottom reassessment of the platform’s architecture, a key outcome of which was the decision to switch to the SuperTrak CONVEYANCE™ platform.